On CNBC’s “Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, picked U.S. 10 Year Treasury.
Liz Thomas, SoFi head of investment strategy, named State Street SPDR S&P Aerospace & Defense ETF (NYSE:XAR) as her final trade.
Don’t forget to check out our premarket coverage here
Kari Firestone, co-founder of Aureus Asset Management, said Thermo Fisher Scientific Inc. (NYSE:TMO) has finally broken out.
TD Cowen analyst Dan Brennan maintained a Buy rating on Thermo Fisher Scientific on Tuesday and raised the price target from $675 to $760, while Morgan Stanley analyst Tejas Savant maintained an Overweight rating and raised the price target from $650 to $730.
Joseph M. Terranova, senior managing director for Virtus Investment Partners, said Pfizer Inc. (NYSE:PFE) surged to a 52-week high.
JPMorgan analyst Chris Schott, on Oct. 9, maintained Pfizer with a Neutral and raised the price target from $28 to $30.
Price Action
- Thermo Fisher shares gained 1.5% to close at $673.20 on Wednesday.
- State Street SPDR S&P Aerospace & Defense ETF fell 1.1% on Wednesday.
- Pfizer shares rose 3% to close at $29.21.
See More:
Top Value Stocks
Photo via Shutterstock
Recent Comments